Moore Michael 4

Accession 0001781905-26-000004

CIK 0001729149other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:56 PM ET

Size

14.8 KB

Accession

0001781905-26-000004

AI-generated summary of this filing

Updated Jan 23, 2026

Viemed (VMD) President Michael Moore Exercises RSUs, Sells Shares

What Happened

Michael Moore, President of Viemed Healthcare (VMD), reported the vesting/conversion of equity awards on Jan 21, 2026. The filing shows conversions/exercises of derivative awards that resulted in the acquisition of shares and simultaneous dispositions back to the issuer to cover taxes and cash settlement.
Specifics: 34,214 and 8,554 derivative units were converted/ exercised (reported as acquisitions). Simultaneously, 9,358 shares were withheld to satisfy tax obligations at $7.49/share (proceeds of $70,091) and 8,554 shares were disposed to the issuer at $7.49/share (proceeds of $64,069). The two cash-related disposals sum to about $134,160. Some derivative items are reported with $0 proceeds reflecting cash-settlement mechanics.

Key Details

Transaction date: January 21, 2026; Form 4 filed January 23, 2026.
Prices used: $7.49 per share (closing market price on Jan 21, 2026, per filing footnote).
Reported dispositions: 9,358 shares withheld for taxes (F2) = $70,091; 8,554 shares sold/disposed to issuer for cash settlement (F4) = $64,069.
Reported acquisitions: conversions/exercises of derivative awards for 34,214 and 8,554 units (codes M — exercise/conversion).
Footnotes of note:
- F1/F5: RSUs represent rights to receive one common share; certain RSUs granted Jan 21, 2025 vest in three equal annual installments.
- F4/F6: Phantom share units (cash-settled) were involved; phantom shares are economically equivalent to common shares and were settled for cash, producing simultaneous acquisition and disposition reporting.
- F2: Shares were withheld to satisfy tax withholding.
Shares owned after the transactions are not provided in the excerpt supplied.
Filing appears to be timely (Form 4 filed two days after the reported date).

Context

This was largely a vesting/conversion event (awards vesting + phantom-share cash settlement) rather than an open-market purchase or voluntary sale. The filing shows a common pattern: equity awards vest, shares are issued, and a portion is immediately withheld or sold to cover taxes or produce cash proceeds.
For retail investors: such transactions are routine compensation-related events and do not by themselves indicate the insider is increasing or materially decreasing a long-term stake (unless additional open-market buys/sells are made).

Form 4

Period: 2026-01-21

President

Transactions

Exercise/Conversion
Common Shares
[F1]
2026-01-21+34,214→ 178,948 total
Tax Payment
Common Shares
[F2][F3]
2026-01-21$7.49/sh−9,358$70,091→ 169,590 total
Exercise/Conversion
Common Shares
[F4]
2026-01-21+8,554→ 178,144 total
Disposition to Issuer
Common Shares
[F3]
2026-01-21$7.49/sh−8,554$64,069→ 169,590 total
Exercise/Conversion
Restricted Stock Units
[F1][F5]
2026-01-21−34,214→ 68,428 total
Exp: 2028-01-21→ Common Shares (34,214 underlying)
Exercise/Conversion
Phantom Share Units
[F4][F6]
2026-01-21−8,554→ 17,107 total
Exp: 2028-01-21→ Common Shares (8,554 underlying)

Holdings

Footnotes (6)

[F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
[F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
[F3]Per share value is based on the market closing price of the common shares for January 21, 2026.
[F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
[F5]Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.
[F6]Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Signature

/s/ Jesse Bergeron, Attorney-in-Fact|2026-01-23

1 file

VIEMED HEALTHCARE, INC.

CIK 0001729149

Entity typeother